Nuclear medicine radioisotopes refer to isotopes that can spontaneously emit radiation. Specifically, radioisotopes refer to isotopes of elements that undergo radioactive decay and have the same atomic number (i.e., the same number of protons, therefore occupying the same position in the periodic table) but different mass numbers (i.e., different numbers of neutrons). These unstable elements will transform into stable atoms after emitting alpha, beta, gamma and other radiation.

In nuclear medicine, radioisotopes are widely used for diagnosing and treating diseases, such as using various radiation emitted by them for radioimmunoassay techniques, radioisotope imaging, or nuclear medicine imaging examinations. These applications fully demonstrate the significant value of radioisotopes in the field of medicine.

Overview of Market Development

According to our research data, the estimated revenue size of the global nuclear medicine radioisotope market in 2024 is $8.29 billion, an increase of 6.96% compared to 2023, and is expected to continue to increase to $112.94 million by 2029. The CAGR for 2029 is estimated to be 6.38%.

Analysis of Downstream Application Pattern

From the perspective of downstream application patterns, nuclear medicine radioisotopes are widely used in fields such as oncology treatment, cardiology treatment, thyroid disease treatment, and nerve disease treatment. Among them, the oncology treatment field is its largest downstream application market, with an estimated application share of 60.55% in 2024.

Source: www.globalmarketmonitor.com

Market Analysis of Major Regions

From a regional perspective, the global market for radioisotopes in nuclear medicine is mainly concentrated in North America, Europe, and the Asia Pacific region. Among them, North America is the largest revenue market. Data shows that the estimated revenue of the North American nuclear medicine radioisotope market in 2024 is $3964 million, and its share of the global total revenue is expected to reach 47.82%; The European and Asia Pacific markets are expected to rank second and third with market shares of 24.48% and 18.35%, respectively.

Regions	Market Revenue (Million USD)	Market Share
North America	3964	47.82%
Europe	2029	24.48%
Asia Pacific	1521	18.35%
South America	435	5.25%
Middle East & Africa	342	4.13%